MedPath

Ablation of Supraventricular Arrhythmias With As Low As Reasonably Achievable X-Ray Exposure

Recruiting
Conditions
Tachycardia, Supraventricular
Registration Number
NCT04716270
Lead Sponsor
Mohamed Bin Khalifa Bin Sulman Al Khalifa Cardiac Centre
Brief Summary

Observational study is to demonstrate a clinically significant reduction of ionizing radiation exposure during transcatheter ablation of supraventricular tachycardias using the EnSite precision mapping system in a real-world clinical setting without compromising efficacy and safety.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
700
Inclusion Criteria
  • Male or female patients ≥ 18 years of age
  • Patient indicated for supraventricular arrhythmias ablation according to the current guidelines
  • Patient is willing to provide written informed consent.
Exclusion Criteria
  • Patient is pregnant.
  • Contraindications to ionizing radiation exposure
  • Patient's life expectancy is less than 1 year
  • Associated complex congenital heart disease
  • Cardiac implantable electric devices
  • Known pathological venous access to the heart

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of procedure related cardiac Adverse Events (Safety)6 months

Cardiac related serious adverse events frequency during and after ablation procedure of supraventricular arrhythmias

Radiation exposure doseThe day of performing the procedure

The dose of ionizing radiation exposure in patients undergoing Supraventricular Tachycardia catheter ablation utilizing a non-fluoroscopic EnSite Precision 3D mapping system

Secondary Outcome Measures
NameTimeMethod
Fluoroscopy timeThe day of performing the procedure

Fluoroscopy time during the procedure

Trial Locations

Locations (1)

Mohamed Bin Khalifa Cardiac Center

🇧🇭

Ar Rifā', Bahrain

© Copyright 2025. All Rights Reserved by MedPath